Nina Kjellson
InvestorGeneral Partner at Canaan Partners · Board director at Annum Health · Board director at Cidara Therapeutics · Board director at Eiger BioPharmaceuticals
Menlo Park, California
Writes $250K – $20M checks · typically $10M
Find your path to Nina
740 people in our graph can introduce you to Nina.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Maya Matthews to introduce you to Nina
You →Maya · together at All Raise 2021 (2021) →Nina
Ask Jamie Chen to introduce you to Nina
You →Jamie · 2 people · together at All Raise 2021 →Nina
Ask Sam Okafor to introduce you to Nina
You →Sam · 9 people · together at Canaan Partners →Nina
Sign up to find every way you can get introduced to Nina
- Your email: the people you already email who know Nina
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Nina
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Nina Kjellson brings a Nordic perspective to biotech, focusing on therapeutics for serious underserved conditions like addiction and neurological disease, and champions women in healthcare and tech via WoVen podcast
Likely emails· guessed from name + firm domain, not firm-published
- n•••@canaan.comreveal100% confident
- n•••@canaan.comreveal75% confident
Invests in
BiotechConsumerDeep TechEnterprise SoftwareFintechHardware
Board director at Annum Health
Intro paths
In turn, Nina can intro founders to Annum Health's investors below.
Board director at Cidara Therapeutics
Intro paths
In turn, Nina can intro founders to Cidara Therapeutics's investors below.
Cidara Therapeutics's investors · 8
Co-founders at Cidara Therapeutics


Board director at Eiger BioPharmaceuticals
Intro paths
In turn, Nina can intro founders to Eiger BioPharmaceuticals's investors below.
Experience
- Pelican Advisors LLC - Family Office and AdvisoryPartnercurrent2024 — present
- Canaan PartnersGeneral Partnercurrent2015 — presentMenlo Park, CA
- Actio Biosciences, Inc.Board Membercurrent2023 — present
- ProxygenBoard Membercurrent2023 — presentVienna, Austria
- Rondo TherapeuticsBoard Membercurrent2022 — present
- Trishula Therapeutics, Inc.Board Membercurrent2020 — present
- Tizona Therapeutics, Inc.Board Membercurrent2016 — presentSan Francisco Bay Area
- Biotechnology Innovation OrganizationBoard Membercurrent2024 — present
- Foundation for the National Institutes of HealthBoard Membercurrent2024 — present
- The Aspen InstituteHealth Innovators' Fellowcurrent2018 — present
- All RaiseMembercurrent2021 — present
- Life Science Cares Bay AreaCo-Chair Board of Trustees - nonprofitcurrent2020 — present
- Girl EffectBoard Member - nonprofitcurrent2019 — present
- WoVen: platform amplifying the ambitions and achievements of women who ventureFoundercurrent2014 — present
- Sardona TherapeuticsBoard Member2021 — 2025
- Blueprint Health LLCMentor2012 — 2025New York City Metropolitan Area
- Blueprint Health LLCMentor2011 — 2015
- Tyra BiosciencesBoard Member2020 — 2025
- Panacea Acquisition Corp. IIBoard Member2021 — 2023
- Essential Access HealthChairwoman - nonprofit2016 — 2023San Francisco Bay Area
- PACT PharmaBoard Member2018 — 2022San Francisco Bay Area
Skills & more
+8 more
EntrepreneurshipGo-to-market StrategyVenture FinancingAngel InvestingGrowth CapitalStart-upsDrug DiscoveryBusiness DevelopmentFrom Nina's professional profile.
Deals · 7
TYRA BiosciencesBoard seat
via Canaan Partners · filed Feb 2024 · $200M raise
Vitruvian NetworksBoard seat
via Canaan Partners · filed Apr 2018 · $33.5M raise
Annum HealthBoard seat
via Canaan Partners · filed Oct 2016 · $2.5M raise
Virgin PulseBoard seat
via Canaan Partners · filed Dec 2015 · $45M raise
LyceraBoard seat
via Canaan Partners · filed Jun 2015
Eiger BioPharmaceuticalsBoard seat
via Canaan Partners · filed Mar 2015 · $14.6M raise
Cidara TherapeuticsBoard seat
via Canaan Partners · filed Feb 2015 · $42M raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Investor
Actio BiosciencesAlt12 AppsAlvine PharmaceuticalsAPT PharmaceuticalsCebixDauntless PharmaceuticalsIntrepida BioLabrys BiologicsOcera TherapeuticsPrimeraDx (Primera Biosystems)Rondo TherapeuticsStandard BioToolsTesaroTizona TherapeuticsTrishula Therapeutics, Inc.VinetiWelltok
Sources: SEC Form D filings · curated public sources.
Colleagues at Canaan Partners
Frequently asked questions
- Who is Nina Kjellson?
- Nina Kjellson brings a Nordic perspective to biotech, focusing on therapeutics for serious underserved conditions like addiction and neurological disease, and champions women in healthcare and tech via WoVen podcast
- Where does Nina Kjellson work?
- Nina Kjellson is General Partner at Canaan Partners and Board director at Annum Health and Board director at Cidara Therapeutics and Board director at Eiger BioPharmaceuticals.
- What does Nina Kjellson invest in?
- Nina Kjellson invests in Biotech, Consumer, Deep Tech, Enterprise Software, Fintech, Hardware.
- What check size does Nina Kjellson write?
- Nina Kjellson typically writes checks of $250K – $20M.
- What boards does Nina Kjellson sit on?
- Nina Kjellson holds tracked board seats at Annum Health, Cidara Therapeutics, Eiger BioPharmaceuticals, Eiger BioPharmaceuticals, Lycera, TYRA Biosciences, Virgin Pulse, Vitruvian Networks.
- What companies has Nina Kjellson invested in?
- Investments tracked here include Actio Biosciences, Alt12 Apps, Alvine Pharmaceuticals, APT Pharmaceuticals, Cebix, Cidara Therapeutics, Dauntless Pharmaceuticals, Eiger BioPharmaceuticals, Intrepida Bio, Labrys Biologics, Lycera, Ocera Therapeutics, and 9 more.
- Where did Nina Kjellson go to school?
- Nina Kjellson studied at Stanford University (BA, Human Biology); Phillips Exeter Academy.
Same school
Also attended Stanford University2,000
+ 1,994 more
Also attended Phillips Exeter Academy151
+ 145 more
Shared employers
Also worked at Foundation for the National Institutes of Health3
Also worked at The Aspen Institute155
+ 149 more
Also worked at All Raise57
+ 51 more















































